Medicines and medical devices regulation post-Brexit

par Matthew Royle, Ph.D.

Pemetrexed in Germany: Federal Court of Justice sets aside decision of Appeal Court

par Christoph de Coster, LL.M. (UC Davis) et Julius Zacharias

Intellectual Property in the Life Sciences, in review

par Dr Paul England

Supreme Court ruling on penalty clauses: consequences for bad leaver provisions

par Debbie Cloake

Strategic considerations - why opt-out or why not?

par Dr. Anja Lunze, LL.M.

Using intellectual property protection

par Colin McCall